Page last updated: 2024-08-24

o-(6)-methylguanine and Malignant Melanoma

o-(6)-methylguanine has been researched along with Malignant Melanoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eich, M; Kaina, B; Nikolova, T; Roos, WP1
Benharroch, D; Brkic, G; Galron, D; Gefen, N; Gopas, J; Ozer, J; Priel, E1
Dianov, GL; Digweed, M; Eich, M; Kaina, B; Roos, WP1
Kyrtopoulos, SA1
Cooper, DP; Crowther, D; Lee, SM; Margison, GP; O'Connor, PJ; Thatcher, N1
Ganesan, TS; Harris, AL; Kyrtopoulos, SA; Mitchell, K; Philip, PA; Salisbury, A; Souliotis, VL; Tates, AD; van Delft, JH1
Arance, A; Lee, SM; Margison, GP; Middleton, MR; Thatcher, N; Wood, M1
Dempke, W; Nehls, P; Osieka, R; Schmidt, CG; Soll, D; Wandl, U1

Reviews

1 review(s) available for o-(6)-methylguanine and Malignant Melanoma

ArticleYear
Variability in DNA repair and individual susceptibility to genotoxins.
    Clinical chemistry, 1995, Volume: 41, Issue:12 Pt 2

    Topics: Animals; Antineoplastic Agents, Alkylating; DNA; DNA Repair; Environmental Exposure; Genetic Predisposition to Disease; Guanine; Hodgkin Disease; Humans; Melanoma; Methyltransferases; Mutagens; O(6)-Methylguanine-DNA Methyltransferase

1995

Trials

1 trial(s) available for o-(6)-methylguanine and Malignant Melanoma

ArticleYear
O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study.
    International journal of cancer, 2000, Nov-01, Volume: 88, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Administration Schedule; Female; Guanine; Humans; Male; Melanoma; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide

2000

Other Studies

6 other study(ies) available for o-(6)-methylguanine and Malignant Melanoma

ArticleYear
Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:11

    Topics: Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Checkpoint Kinase 1; Dacarbazine; DNA Breaks, Double-Stranded; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Glioblastoma; Guanine; Humans; Melanoma; Methylnitronitrosoguanidine; Phosphorylation; Protein Kinases; Signal Transduction; Temozolomide; Tumor Suppressor Proteins

2013
Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT).
    Cancer biology & therapy, 2010, Volume: 9, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; DNA Methylation; Dose-Response Relationship, Drug; Guanine; Humans; Melanoma; O(6)-Methylguanine-DNA Methyltransferase; Thioguanine

2010
Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
    Molecular pharmacology, 2010, Volume: 78, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Caspase 7; Cell Cycle Proteins; Cell Line, Transformed; Cell Line, Tumor; Dacarbazine; DNA Methylation; Drug Resistance, Neoplasm; Fibroblasts; Guanine; Homozygote; Humans; Melanoma; Methylnitronitrosoguanidine; Mutagens; Mutation; Necrosis; Nijmegen Breakage Syndrome; Nuclear Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Temozolomide; Uveal Neoplasms

2010
Relationships between the formation of O6-methyldeoxyguanosine by 1-p-carboxyl-3,3-dimethylphenyltriazene in DNA and O6-alkylguanine-DNA alkyltransferase in human peripheral leukocytes.
    Cancer research, 1994, Aug-01, Volume: 54, Issue:15

    Topics: Adult; Aged; Antineoplastic Agents; Deoxyguanosine; DNA Nucleotidyltransferases; DNA, Neoplasm; Female; Guanine; Humans; Leukocytes; Lymphocytes; Male; Melanoma; Middle Aged; Triazenes

1994
Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; DNA Adducts; DNA Repair; Female; Guanine; Humans; Hydroxyurea; Hypoxanthine Phosphoribosyltransferase; Leukocytes; Male; Melanoma; Middle Aged; Mutation; O(6)-Methylguanine-DNA Methyltransferase

1996
Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cells.
    Journal of cancer research and clinical oncology, 1987, Volume: 113, Issue:4

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Colony-Forming Units Assay; Cross-Linking Reagents; Drug Resistance; Drug Synergism; Guanine; Humans; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Nitrosourea Compounds; Semustine; Transplantation, Heterologous; Tumor Stem Cell Assay

1987